Reduction of urinary levels of N-telopeptide correlates with treatment compliance in women with postmenopausal osteoporosis receiving alendronate

dc.contributor.author	Palacios, Santiago
dc.contributor.author	Neyro, José Luis
dc.contributor.author	Ferrer Barriendos, Francisco Javier
dc.contributor.author	Villero, José
dc.contributor.author	Cañada, Enrique
dc.contributor.author	Redondo, Esther
dc.contributor.author	Caloto, María Teresa
dc.contributor.author	Nocea, Gonzalo
dc.date.accessioned	2013-01-30T09:59:41Z
dc.date.available	2013-01-30T09:59:41Z
dc.date.issued	2012
dc.identifier.citation	Menopause-the Journal of the North American Menopause Society, 19(1), p. 67-74 (2012); doi:10.1097/gme.0b013e3182214f5a	spa
dc.identifier.issn	1072-3714
dc.identifier.uri	http://hdl.handle.net/10651/6730
dc.description.statementofresponsibility	Palacios, S., Neyro, J.L., Ferrer, J., Villero, J., Cañada, E., Redondo, E., Caloto, M.T., Nocea, G.
dc.format.extent	p. 67-74	spa
dc.language.iso	eng
dc.relation.ispartof	Menopause-the Journal of the North American Menopause Society	spa
dc.source	WOK	spa
dc.title	Reduction of urinary levels of N-telopeptide correlates with treatment compliance in women with postmenopausal osteoporosis receiving alendronate	spa
dc.type	journal article
dc.identifier.local	20120091	spa
dc.identifier.doi	10.1097/gme.0b013e3182214f5a
dc.relation.publisherversion	http://dx.doi.org/10.1097/gme.0b013e3182214f5a	spa

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.